Boston Scientific returns to Hanscom after a week of M&A and guidance cuts

Boston Scientific flew from Rhode Island T. F. Green International Airport to its home base at Laurence G Hanscom Field on June 11, a 22-minute hop in its Bombardier Challenger 650 (N650BS). The flight arrived just before 10:13 PM local time, capping a day that likely began with a meeting or event in the Providence area.

The same week, Boston Scientific was in the headlines for two reasons. On June 11, MedTech Dive reported that CEO Mike Mahoney had slashed the company's 2026 sales growth guidance from a range of 10.5% to 11.5% down to 7% to 8.5%, citing challenges in electrophysiology, the Watchman franchise, and urology. Just days earlier, on May 18, the company announced a $1.5 billion strategic investment in MiRus LLC for a 34% equity stake, with an option to acquire the TAVR business for up to $3 billion more, per a company press release. Mahoney also presented at the Bernstein 42nd Annual Strategic Decisions Conference on May 27, a regular stop for medtech executives.

The flight from KPVD to KBED is a short repositioning leg, but it fits a pattern: Boston Scientific's aircraft frequently shuttles between Hanscom and regional airports like Teterboro, Morristown, and Dallas Love Field, supporting a busy calendar of investor meetings, regulatory filings, and corporate travel. The company's home base remains Hanscom Field, where the Challenger 650 returned after a day that likely involved internal discussions about the lowered outlook and the MiRus deal.